Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma

NCT00570180

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • CancerCare Manitoba 675 McDermot Ave. Winnipeg, Manitoba, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
  • London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada
View Trial Details
Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT01605032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Cancer Institute New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916

NCT02064387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions